Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D
Recommended Retatrutide Dose Escalation Schedule Retatrutide is initiated at a low dose and titrated upward at approximately four-weekly intervals, targeting up to 12 mg once weekly in the highest-dose trial arm
It has been demonstrated that the inhibitory action of GLP-1 on the GIT is mediated through a vagal pathway
Liver enzymes, particularly AST and ALT, decreased significantly during treatment, suggesting potential hepatic benefits
10.1016/j.bbamcr.2022.119300 [DOI] [PubMed] [Google Scholar] Wu M., Liao M., Huang R., Chen C., Tian T., Wang H., et al
For his part, Igor Sapozhnikov, MD, an obesity medicine doctor in Los Angeles, believes skin changes are less about GLP-1 medications themselves and more about how quickly a patient is losing weight